Stock Information
Corvus Pharmaceuticals Inc (CRVS)
Ticker Symbol: CRVS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,097.08 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.1774
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -23.29%
Latest News
-
Corvus Pharmaceuticals: Strong Clinical Narrative, Already Priced For Success
Wed, Apr 8, 2026 5:22 AM
Key Financials
Financial data not available